ClearBridge Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

ClearBridge Investments’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,039	Closed	-$65K	–	1028
2020 Q2	$65K	Hold	1,039	–	–	﹤0.01%	772
2020 Q1	$44K	Sell	1,039 -35	-3%	-$1.6K	﹤0.01%	786
2019 Q4	$50K	Hold	1,074	–	–	﹤0.01%	827
2019 Q3	$49K	Hold	1,074	–	–	﹤0.01%	823
2019 Q2	$63K	Sell	1,074 -18,839	-95%	-$974K	﹤0.01%	803
2019 Q1	$893K	Buy	19,913 +3	+0%	+$138	﹤0.01%	683
2018 Q4	$775K	Sell	19,910 -10	-0.1%	-$393	﹤0.01%	701
2018 Q3	$917K	Sell	19,920 -31	-0.2%	-$1.26K	﹤0.01%	731
2018 Q2	$870K	Buy	19,951 +16,480	+475%	+$708K	﹤0.01%	657
2018 Q1	$137K	Buy	3,471 +1,118	+48%	+$43.5K	﹤0.01%	763
2017 Q4	$80K	Hold	2,353	–	–	﹤0.01%	801
2017 Q3	$60K	Hold	2,353	–	–	﹤0.01%	824
2017 Q2	$40K	Buy	2,353 +97	+4%	+$1.33K	﹤0.01%	891
2017 Q1	$33K	Hold	2,256	–	–	﹤0.01%	926
2016 Q4	$32K	Buy	2,256 +12	+0.5%	+$186	﹤0.01%	915
2016 Q3	$39K	Buy	+2,244	New	+$37.2K	﹤0.01%	885

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

ClearBridge Investments's ARNA Position: Q3 2020 in Review

ClearBridge Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 1,039 shares — an estimated $65K sold.

ClearBridge Investments first reported a position in ARNA in Q3 2016 and held it in 16 quarters. The position peaked at $917K in Q3 2018. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

ClearBridge Investments reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
ClearBridge Investments sold 1,039 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $65K.
ClearBridge Investments first reported a position in Arena Pharmaceuticals Inc in Q3 2016 and held it in 16 quarters.
ClearBridge Investments's Arena Pharmaceuticals Inc position peaked at $917K in Q3 2018.
253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on ClearBridge Investments's 13F filing for Q3 2020, filed 12 Nov 2020.